1-BUTYL-3-METHYL-1H-IMIDAZOL-3-IUM TRIFLUOROMETHANESULFONATE, 95%, 25g

Methyl4-hydroxy-3,5-dimethyl-benzoate, 98+%, 2g

N-methyl-1-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethanamine oxalate, 95.0%, 1g

bicyclo[2.2.1]heptan-1-amine hydrochloride, 95.0%, 1g

4,5-Dibromo-2-fluorobenzaldehyde, 95.0%, 250mg

Hexadecyltrimethylammonium Perchlorate>98.0%(N)1g

5-(5,5-dimethyl-1,3-dioxan-2-yl)-3',5'-dimethyl-4'-methoxyvalerophenone, 97.0%, 1g

1-tert-butyl 3-methyl (3S,4R)-rel-4-methylpiperidine-1,3-dicarboxylate, 97.0%, 1g

2-Bromoquinoxaline>98.0%(GC)200mg

(4-Bromo-2-fluorophenyl)(3,3-dimethylazetidin-1-yl)methanone, 98+%, 100mg

5-methyl-2H-indazole-4-carboxylic acid, 97%, 1g

Nazartinib, 100mg

4-(Methylsulfinyl)phenol, 95.0%, 25g